5-(4-methoxyphenyl)-2-methylpyrazol-3-amine, 97%, 250mg

N-(2,2,2-trifluoroethyl)-1,4-diazepane-1-sulfonamide hydrochloride, 95.0%, 500mg

8-Oxo-8-(4-isopropoxyphenyl)octanoic acid, 97.0%, 1g

(S)-2-Amino-3-(3-chloro-2-fluorophenyl)propanoic acid hydrochloride, 95.0%, 250mg

3',4'-Difluoroacetophenone, 97.0%, 100g

N-Boc-4,5,6,7-Tetrahydro-thieno[2,3-c]pyridine-3-carboxylic acid ethyl ester, 97.0%, 250mg

5-METHOXY-2-(((TETRAHYDRO-2H-PYRAN-2-YL)OXY)METHYL)-4H-PYRAN-4-ONE, 90.0%, 500mg

2-(4-Aminomethyl-piperidin-1-yl)-ethanol, 95.0%, 5g

4-Chloro-3-(trifluoromethyl)-5-(phenyl)pyrazole, 97.0%, 5g

(Z)-3-(4-(dimethylamino)phenyl)acrylonitrile, 98%, 5g

Lithium ICP-Standardlösung, ROTI®Star, 10000 mg/l Li, Dichte (D) ~1 g/cm³

4-[(4-Formylphenoxy)methyl]benzoic acid, 97%, 5g

4-Methyl-N-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-N-(p-tolyl)aniline, 98%, 5g